Article

Clinical Features of Rheumatic Patients with Biologics Treatment Infected with COVID-19 in China

2023-05-11

Abstract excerpt

Objective: This study aimed to investigate the clinical features and condition changes of COVID-19 in rheumatic patients with biologics treatment, given the chronic nature of rheumatic diseases and their increased susceptibility to infections.<br><br>Methods: An anonymous questionnaire was administered to 1044 respondents, including 131 patients receiving biologics treatment to investigate demographics, clinical c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2df2521f-bfb0-5ac0-a6d2-644ef9c0d0eb
DOI: 10.2139/ssrn.4444428

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical Features of Rheumatic Patients with Biologics Treatment Infected with COVID-19 in ChinaDOI 10.2139/ssrn.4444428Read

How Did COVID-19 Pandemic Affect Rheumatology Out-Patients Practice? A Single-Center Experience from TurkeySemantic proximity Read

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugsSemantic proximity Read

Covid 19 Infection in Patients with Rheumatic Immune-Mediated Diseases in a Single University Hospital. Matched Case-Control Study and Literature Review.Semantic proximity Read

Biologic agents for rheumatic diseases in the break of COVID-19: friend or foe?Semantic proximity Read

Does Biological Therapy Protect against Severe COVID-19?Semantic proximity Read

Immuno-inflammatory rheumatic diseases and COVID-19: analysis of clinical outcomes according to the data of the register of patients of the Novosibirsk region receiving therapy with genetically engineered biological drugsSemantic proximity Read

DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective studySemantic proximity Read

A Prospective Longitudinal Study Evaluating The Influence of Immunosuppressives and Other Factors On COVID-19 in Autoimmune Rheumatic DiseasesSemantic proximity Read

Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this conditionSemantic proximity Read

Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort studySemantic proximity Read

Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in ScotlandSemantic proximity Read

Different Covid-19 Outcomes Among Systemic Rheumatic Diseases: A Nation-wide Cohort StudySemantic proximity Read